4BIO pulls Development Bank of Japan to dip its toes into UK life science by backing latest fund

Japan’s sov­er­eign in­vest­ment bank has inked an in­vest­ment agree­ment for VC firm 4BIO Cap­i­tal’s third fund, mark­ing the in­sti­tu­tion­al in­vestor’s ini­tial ven­ture in­to the UK life sci­ences sec­tor.

The Lon­don-based VC firm is look­ing to raise be­tween $200 mil­lion and $300 mil­lion for its lat­est ven­ture fund, the close of which is an­tic­i­pat­ed lat­er this year. Mean­while, 4BIO Ven­tures III is al­ready de­ploy­ing cap­i­tal with a fo­cus on “ad­vanced ther­a­pies” and “emerg­ing tech­nolo­gies” such as cell and gene ther­a­pies, RNA-based drugs and the mi­cro­bio­me, ac­cord­ing to a com­pa­ny re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.